Integrin-IN-27

CAS No. 593274-97-6

Integrin-IN-27( MDK-4976 | Integrin Antagonist 27 | MDK4976 | MDK 4976 )

Catalog No. M15199 CAS No. 593274-97-6

A potent integrin αvβ3 antagonist with IC50 of 18 nM; could be conjugated to paclitaxel for selective delivery to alphavbeta3 positive metastatic cancer cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 312 Get Quote
50MG 1341 Get Quote
100MG 1791 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Integrin-IN-27
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent integrin αvβ3 antagonist with IC50 of 18 nM; could be conjugated to paclitaxel for selective delivery to alphavbeta3 positive metastatic cancer cells.
  • Description
    A potent integrin αvβ3 antagonist with IC50 of 18 nM; could be conjugated to paclitaxel for selective delivery to alphavbeta3 positive metastatic cancer cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    MDK-4976 | Integrin Antagonist 27 | MDK4976 | MDK 4976
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Integrin
  • Recptor
    Integrin
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    593274-97-6
  • Formula Weight
    444.4394
  • Molecular Formula
    C24H20N4O5
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C(O)C1=CC=CC(N2C(/C=C(C(N3CC(NC4=CC=C(C)C=C4)=O)=O)/NC3=O)=CC=C2)=C1
  • Chemical Name
    Benzoic acid, 3-[2-[[1-[2-[(4-methylphenyl)amino]-2-oxoethyl]-2,5-dioxo-4-imidazolidinylidene]methyl]-1H-pyrrol-1-yl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Dayam R, et al. J Med Chem. 2006 Jul 27;49(15):4526-34.
molnova catalog
related products
  • Abciximab

    Abciximab (C7E3) is a mouse/human chimeric monoclonal antibody that is a potent glycoprotein IIb/IIIa inhibitor.

  • RBC8

    RBC8 is a specific GTPases RalA/RalB inhibitor by inhibiting the binding of Ral to its effector RALBP1, no inhibition on the GTPases RhoA and Ras.

  • α2β1 Integrin Ligand...

    The Asp-Gly-Glu-Ala (DGEA) amino acid domain of type I collagen interacts with the α2β1 integrin receptor on the cell membrane and mediates extracellular signals into cells. It is a potential antagonist of collagen receptors.